Jazz Pharmaceuticals CEO: We are not going to sell Vivint’s stock to Pfizer
Jazz Pharmaceutical, the company behind Vivint and other drugs for rare and serious diseases, said Thursday that it will not be selling its stock to pharmaceutical company Pfizer.“The board is not sold on the merits of the acquisition,” Jazz said in a statement.The company said it is not taking any additional actions.Pfizer has long been…